These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6648868)

  • 1. Effect of aerosol fenoterol on the severity of bronchial hyperreactivity in patients with asthma.
    Salome CM; Schoeffel RE; Yan K; Woolcock AJ
    Thorax; 1983 Nov; 38(11):854-8. PubMed ID: 6648868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of aerosol and oral fenoterol on histamine and methacholine challenge in asthmatic subjects.
    Salome CM; Schoeffel RE; Woolcock AJ
    Thorax; 1981 Aug; 36(8):580-4. PubMed ID: 7031973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect throughout the day of inhaled fenoterol on the bronchial responsiveness to histamine in asthmatic patients.
    Carpentiere G; Castello F; Marino S
    Respiration; 1987; 52(1):16-21. PubMed ID: 3659581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regular inhaled beta agonist in asthma: effects on exacerbations and lung function.
    Taylor DR; Sears MR; Herbison GP; Flannery EM; Print CG; Lake DC; Yates DM; Lucas MK; Li Q
    Thorax; 1993 Feb; 48(2):134-8. PubMed ID: 8493626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of SCH 1000 on bronchial hyperreactivity compared to that of fenoterol].
    Dakhil J; Clauzel AM; Michel FB
    Respiration; 1984; 46(4):370-8. PubMed ID: 6240749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of SCH 1000 and fenoterol after histamine-induced bronchoconstriction in asymptomatic asthmatics.
    Scano G; Stendardi L; Gigliotti F; Esposito-Iacenna V; Sergysels R; Bracamente M; De Coster A
    Int J Clin Pharmacol Ther Toxicol; 1984 Feb; 22(2):81-5. PubMed ID: 6230326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of an inhaled neutral endopeptidase inhibitor, phosphoramidon, on baseline airway calibre and bronchial responsiveness to bradykinin in asthma.
    Crimi N; Polosa R; Pulvirenti G; Magrì S; Santonocito G; Prosperini G; Mastruzzo C; Mistretta A
    Thorax; 1995 May; 50(5):505-10. PubMed ID: 7597662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histamine-induced bronchial response after administration of placebo, salbutamol and a combination of a beta-2-adrenergic drug (fenoterol) with an anticholinergic agent (ipratropium bromide) in asymptomatic asthma patients.
    Fontana G; Mugnai M; Cresci F; Panuccio P
    Respiration; 1986; 50 Suppl 2():201-5. PubMed ID: 2951806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of ipratropium and fenoterol on methacholine-histamine-induced bronchoconstriction.
    Bandouvakis J; Cartier A; Roberts R; Ryan G; Hargreave FE
    Br J Dis Chest; 1981 Jul; 75(3):295-305. PubMed ID: 6457620
    [No Abstract]   [Full Text] [Related]  

  • 10. Aerosol administration of fenoterol hydrobromide (Th 1165a) in subjects with reversible obstructive airway disease.
    Pennock BE; Rogers RM; Ryan BR; Ayers LN
    Chest; 1977 Dec; 72(6):731-6. PubMed ID: 336306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment of exercise-induced asthma by fenoterol delivered as inhalation powder and pressurized aerosol.
    Bundgaard A; Schmidt A
    Ann Allergy; 1982 Jan; 48(1):36-9. PubMed ID: 7055343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchial responsiveness during regular fenoterol therapy: four months prospective study.
    Town GI; O'Donnell TV; Purdie G
    N Z Med J; 1991 Jan; 104(904):3-5. PubMed ID: 2008260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind crossover study on the protective effect of fenoterol--administered by pressurized aerosol and in powder form--in allergen-induced asthma.
    D'Amato G; Schiano M; Cocco G; Melillo G
    Respiration; 1984; 45(3):276-80. PubMed ID: 6379789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of fenoterol aerosol in asthma.
    Chervinsky P
    Ann Allergy; 1977 Sep; 39(3):179-83. PubMed ID: 900585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of prior treatment with salmeterol and formoterol on airway and systemic beta 2 responses to fenoterol.
    Grove A; Lipworth BJ
    Thorax; 1996 Jun; 51(6):585-9. PubMed ID: 8693438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fenoterol dose-response study in children with asthma.
    Feldman CH; Sher TH; Hutchinson VE; Feldman BR; Davis WJ
    J Allergy Clin Immunol; 1984 Mar; 73(3):356-62. PubMed ID: 6699315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-response characteristics of nebulized fenoterol in asthmatic children.
    Reilly PA; Yahav J; Mindorff C; Kazim F; Levison H
    J Pediatr; 1983 Jul; 103(1):121-6. PubMed ID: 6864377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dose-response study on fenoterol (Berotec) solution by inhalation in asthmatic children.
    Blackhall MI; Macartney B; O'Donnell SR
    Dev Pharmacol Ther; 1983; 6(6):374-80. PubMed ID: 6357677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low dose fenoterol aerosol protects against histamine-induced bronchoconstriction in mild asthmatics: a dose response study.
    Magnussen H; Rabe KF
    Clin Exp Allergy; 1992 Jul; 22(7):690-3. PubMed ID: 1504891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind trial with standard doses of fenoterol and salbutamol in asthmatic children.
    Graff-Lonnevig V
    Acta Allergol; 1976 Dec; 31(6):463-70. PubMed ID: 797215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.